Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATNM
Stock Latest News
Ratings
Analyst Reiterates Buy on Actinium, Keeps $4 Price Target Amid Advancing Radiotherapy Pipeline and 2026–2027 Catalysts
6d ago
ATNM
Premium
Ratings
Reinforced Buy on Actinium: Strengthening ATNM-400 Pan-Tumor Data and Expanding Actimab-A AML Opportunities Drive Pipeline Upside
26d ago
ATNM
Premium
The Fly
Actinium presents data from Actimab-A studies at AACR
26d ago
ATNM
Premium
The Fly
Actinium presents preclinical results for ATNM-400 at AACR
26d ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Undervalued Radiopharmaceutical Play with Promising ATNM-400 Pipeline and Near‑Term Catalysts
1M ago
ATNM
Premium
Pre-Earnings
Is ATNM a Buy, Before Earnings?
2M ago
ATNM
Premium
Ratings
Promising Potential of Actinium Pharmaceuticals’ ATNM-400 Drives Buy Rating
5M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments and Strong Financial Position Drive Buy Rating
5M ago
ATNM
Premium
Ratings
Promising Preclinical Data for ATNM-400 Reinforces Buy Rating for Actinium Pharmaceuticals
5M ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals presents new data on anti-tumor activity of ATNM-400
5M ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals announces preclinical data for ATNM-400
6M ago
ATNM
Premium
Company Announcements
Actinium Pharmaceuticals Holds Annual Stockholders Meeting
6M ago
8K
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating
6M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments and Strong Financial Health Support Buy Rating
6M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating
6M ago
ATNM
Premium
Ratings
Actinium Pharmaceuticals: Promising Preclinical Success and Innovative Radiotherapy Developments Drive Buy Rating
7M ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
7M ago
AZN
JNJ
Premium
Ratings
Actinium Pharmaceuticals’ ATNM-400: A Promising Radiotherapeutic Advancing Oncology Treatment Options
7M ago
ATNM
Premium
The Fly
Actinium presents preclinical data for ATNM-400
7M ago
ATNM
Premium
Ratings
Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals
7M ago
ATNM
Premium
The Fly
Actinium Pharmaceuticals to announces preclinical data from ATNM-400 program
7M ago
ATNM
Premium
Company Announcements
Actinium Pharmaceuticals’ New AML Treatment Study: A Potential Game Changer
8M ago
ATNM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
